APA (7th ed.) Citation

Spellberg, B., Miller, L. G., Kuo, M. N., Bradley, J., Scheld, W. M., & Edwards Jr., J. E. (2007). Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic Development. Infection, 35(3), 167. https://doi.org/10.1007/s15010-007-6269-7

Chicago Style (17th ed.) Citation

Spellberg, B., L. G. Miller, M. N. Kuo, J. Bradley, W. M. Scheld, and J. E. Edwards Jr. "Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic Development." Infection 35, no. 3 (2007): 167. https://doi.org/10.1007/s15010-007-6269-7.

MLA (9th ed.) Citation

Spellberg, B., et al. "Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic Development." Infection, vol. 35, no. 3, 2007, p. 167, https://doi.org/10.1007/s15010-007-6269-7.